Here’s whether Sabra Healthcare REIT, Inc. (SBRA) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.20% over 10 days); strong 1-year return of +21.7%; 3-month momentum positive (+11.3%). Concerns: RSI 80 — overbought, elevated pullback risk. Currently 0.8% off its 52-week high. Score: +5/7.
SBRA is in a confirmed uptrend, trading above both its 50-day ($19.76) and 200-day ($19.46) moving averages. With an RSI of 79.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +21.7% compares to +16.5% for SPY (beat the market by 5.3%).
$10,000 invested 1 year ago→ $12,172 today
vs. S&P 500 (SPY) — same period beat market by 5.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($19.46)
✓Above 50-day MA ($19.76)
!RSI(14) neutral zone (30–70) — currently 79.7
✓Positive return (+21.7%)
✓Within 10% of period high (−0.8%)
Period Range $22.36
$17.17$22.55
RSI (14) 79.7
0 · OversoldOverbought · 100
Key Metrics
Price$22.36
Period Return+21.7%
Period High$22.55
Period Low$17.17
Drawdown−0.8%
MA-50$19.76
MA-200$19.46
RSI (14)79.7
Avg Volume (30d)3.6M
vs. SPYbeat by 5.3%
Return Rank#351 of 999
Trend Signals
Price is above the 200-day moving average ($19.46)